Lynette Holzbaur - 05 Nov 2026 Form 4 Insider Report for Organon & Co. (OGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Nov 2026, 16:05:33 UTC
Prior SEC filing
07 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tarnetta V. Jones, Attorney-in-Fact for Lynette Holzbaur
Filing notes and source

Key filing fact

Lynette Holzbaur filed Form 4 for Organon & Co. (OGN) on 10 Nov 2026.

Key facts

  • This page summarizes Lynette Holzbaur's Form 4 filing for Organon & Co. (OGN).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 10 Nov 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 07 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002068746 Primary reporting owner

Holzbaur Lynette

Relationship
SVP and Corporate Controller
Address
C/O ORGANON & CO., 30 HUDSON STREET, FLOOR 33, JERSEY CITY
Signature
/s/ Tarnetta V. Jones, Attorney-in-Fact for Lynette Holzbaur
Signature date
10 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OGN transaction

Common Stock

Options Exercise

Transaction value
Shares
+3,038
Change %
Price
$0.000000*
Shares after
3,038
Date
05 Nov 2026
Ownership
Direct
OGN transaction

Common Stock

Tax liability

Transaction value
Shares
-866
Change %
-29%
Price
$13.83*
Shares after
2,172
Date
05 Nov 2026
Ownership
Direct
OGN transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,418
Change %
+111%
Price
$0.000000*
Shares after
4,590
Date
07 Nov 2026
Ownership
Direct
OGN transaction

Common Stock

Tax liability

Transaction value
Shares
-689
Change %
-15%
Price
$13.87*
Shares after
3,901
Date
07 Nov 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OGN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-3,038
Change %
-50%
Price
$0.000000*
Shares after
3,038
Date
05 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,038
Exercise price
Footnotes
F1, F2
OGN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-2,418
Change %
-100%
Price
$0.000000*
Shares after
0
Date
07 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,418
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Organon & Co. common stock.

Footnote F2

9,113 RSUs were granted on November 5, 2024, and one-third vest each year with the final vesting date being November 5, 2027.

Footnote F3

7,252 RSUs were granted November 7, 2023, and one-third vest each year with the final vesting date being November 7, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .